Quoin Pharmaceuticals Ltd (QNRX)
0.7771
+0.08
(+10.86%)
USD |
NASDAQ |
May 31, 16:00
0.7771
0.00 (0.00%)
After-Hours: 20:00
Quoin Pharmaceuticals Enterprise Value: -11.60M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -11.60M |
| May 30, 2024 | -11.90M |
| May 29, 2024 | -11.90M |
| May 28, 2024 | -11.82M |
| May 24, 2024 | -11.74M |
| May 23, 2024 | -11.82M |
| May 22, 2024 | -11.70M |
| May 21, 2024 | -11.70M |
| May 20, 2024 | -11.64M |
| May 17, 2024 | -11.67M |
| May 16, 2024 | -11.60M |
| May 15, 2024 | -11.60M |
| May 14, 2024 | -11.59M |
| May 13, 2024 | -11.55M |
| May 10, 2024 | -11.61M |
| May 09, 2024 | -11.53M |
| May 08, 2024 | -11.55M |
| May 07, 2024 | -11.83M |
| May 06, 2024 | -11.86M |
| May 03, 2024 | -11.74M |
| May 02, 2024 | -11.92M |
| May 01, 2024 | -11.99M |
| April 30, 2024 | -12.00M |
| April 29, 2024 | -12.09M |
| April 26, 2024 | -12.27M |
| Date | Value |
|---|---|
| April 25, 2024 | -12.30M |
| April 24, 2024 | -12.29M |
| April 23, 2024 | -12.18M |
| April 22, 2024 | -12.18M |
| April 19, 2024 | -12.00M |
| April 18, 2024 | -11.96M |
| April 17, 2024 | -11.91M |
| April 16, 2024 | -11.96M |
| April 15, 2024 | -11.98M |
| April 12, 2024 | -11.88M |
| April 11, 2024 | -11.77M |
| April 10, 2024 | -11.72M |
| April 09, 2024 | -11.68M |
| April 08, 2024 | -11.73M |
| April 05, 2024 | -11.61M |
| April 04, 2024 | -11.43M |
| April 03, 2024 | -11.31M |
| April 02, 2024 | -11.33M |
| April 01, 2024 | -11.12M |
| March 28, 2024 | -7.193M |
| March 27, 2024 | -7.488M |
| March 26, 2024 | -7.617M |
| March 25, 2024 | -7.558M |
| March 22, 2024 | -7.599M |
| March 21, 2024 | -7.378M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.30M
Minimum
Apr 25 2024
102.64M
Maximum
Oct 29 2021
-0.978M
Average
-6.854M
Median
Enterprise Value Benchmarks
| Ainos Inc | 10.06M |
| Lipella Pharmaceuticals Inc | 2.777M |
| Ocean Biomedical Inc | 62.95M |
| QT Imaging Holdings Inc | 18.77M |
| Protagenic Therapeutics Inc | 3.430M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.327M |
| Total Expenses (Quarterly) | 2.458M |
| EPS Diluted (Quarterly) | -1.11 |
| Earnings Yield | -943.3% |